Long covid, also known as post COVID-19 condition, is estimated to affect 10-20% of people who develop COVID-19. While the majority go on to fully recover, this group of people suffer a variety of physical, physiological and cognitive symptoms for many weeks, months and sometimes longer. The condition can be debilitating and recovery requires a holistic and personalised care approach, including pharmaceutical care.
This event by FIP aims to explore in more depth what long covid is, what the key characteristics and symptoms are and how these symptoms can be managed in the pharmacy. The panellists include a public health expert on long-covid-19, a clinical pharmacist who is recovering from long covid, a physiotherapist and more.
Learning objectives: 1. Describe the key characteristics and symptoms of long COVID-19 2. Understand the latest research and evidence concerning treatment and care 3. Discuss ways long covid symptoms can be managed in the pharmacy 4. Identify the importance of pharmacists' understanding of the condition and care needs
Moderator: - Leonila Ocampo, FIP Community Pharmacy Section, Asia Pacific Institute for Medication Management Philippine Pharmacists Association, Philippines
Panellists: - Darren Brown, Clinical Academic Physiotherapist, Chelsea and Westminster Hospital NHS Foundation Trust; Long COVID Physio, United Kingdom - Rani Khatib, Consultant Cardiology Pharmacist and Associate Professor University of Leeds, United Kingdom - Lucette Cysique, Associate Professor The University of New South Wales, Australia
The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.
By the end of the session participants should be able to: • Understand the roles pharmacists can play in HIV prevention, screening and management • Recognise some resources and tools that pharmacists can use in this area • Find and use the FIP toolkit on HIV prevention, screening and management
Moderator: - Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
Panellists: - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Ali Ahmed, Ph.D. Final Year Student (Clinical Pharmacy) Monash University Malaysia, Malaysia - Alicia Krüger, Clinical pharmacist Brazilian federal council of pharmacy, Brazil - Elise HARO-BRUNET, Employed pharmacist CESPHARM (prevention committee) / French Chamber of pharmacists, France - Romeo Ongpoy Jr, Dean Emilio Aguinaldo College - Cavite Campus, Philippines - Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, USA
This event will discuss pharmacists’ roles in infectious & tropical disease prevention, and management by improving pharmacists’ knowledge in these diseases as well as showcasing practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications across Africa in the context of infectious and tropical diseases. Pharmacists are uniquely positioned to provide a wide array of services to prevent, and manage infectious and tropical diseases. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of infectious & tropical disease.
Learning objectives 1. Improve knowledge of pharmacists in the scope of infectious & tropical diseases as well as anti-infectives within the African region; 2. Showcase practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications in the context of infectious & tropical diseases as well as anti-infectives within the African region; 3. Identify the needs and priorities of pharmacists in the prevention and management of infectious & tropical diseases within the African region.
Moderator: - Jocelyn Chaibva, Vice president African Pharmaceutical Forum, Zimbabwe
Facilitators: - Nilhan Uzman, FIP Lead for Education and Primary Health Policies, Turkey - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria
Guests: - Mirfin Mpundu, Director ReAct Africa, Kenya - Natalie Schellack, Head of the Department of Pharmacology, University of Pretoria, South Africa - Arinola Joda, Associate Professor University of Lagos, Nigeria
Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.
By the end of the session participants will: - Understand the specific vaccination needs of several special-risk population groups - Become familiar with FIP’s resources on vaccination for special-risk groups - Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Switzerland - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally) - Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine - Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom - Jane Barratt, Secretary-General International Federation on Ageing, Canada - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK
Pharmacists as athlete support personnel have rooted themselves as key players in medical teams serving athletes. Sports pharmacy evolved from a niche practice during the establishment of WADA two decades ago, gaining traction with the publication of the FIP guidelines “The Role of the Pharmacist in the Fight against Doping in Sport” in 2014. Today, we recognise sports pharmacy as a specialty practice, fundamental to the antidoping movement and athlete health. Pharmacists provide accurate sports drug information, avoid inadvertent doping, and coordinate pharmacy services at sporting events. We present two successful models in education and proper training of pharmacists to work with athletes.
Attendees will learn about:
1. Exploring the specialty of sports pharmacy based on expert consensus 2. Discussing a foundation for sports pharmacy curricula 3. Describing a successful example of sports pharmacy practice
Moderator: - Daragh Connolly, Chair Board of Pharmaceutical Practice, Ireland
Panellists: - Ashley Anderson, Clinical Sports Pharmacy Specialist / Antidoping Pharmacist International Sports Pharmacists Network, USA - David Mottram, Emeritus Professor- Liverpool John Moores University, UK - Mark Stuart, Pharmacist to the International Olympic Committee Medical Commission International Olympic Committee, UK - Claire May, Academic University of Brighton, UK - Somer Helvaci, Lecturer IOC accredited sports pharmacist, Turkey - Shigeo Yamamura, Specially-Appointed Professor Josai International University, Japan
One year after the launch of the FIP global call to action on advancing pharmaceutical education, FIP will report on each region’s progress against the call the action, building on the results of the FIP-UNITWIN intra-regional impact workshops help in November 2022. The event will also host the launch of the FIP Education transformation toolkit, which will be a one stop shop consolidating FIP’s relevant publications and digital events to implement the FIP global call to action on advancing pharmaceutical education.
Present progress since 2021 on priority FIP Development Goals of the regions in the context of pharmaceutical education
Present progress on FIP-UNITWIN regional roadmaps 2021 and FIP global call to action on pharmaceutical education
Discuss the way forward for the delivery of each regions’ roadmaps with FIP-UNITWIN centre for excellence programme and FIP Education transformation toolkit